Andera Partners
Investor profile | Builders Republic
About
Andera Partners is a major European multi-strategy investment firm. Formerly known as Edmond de Rothschild Investment Partners (EdRIP), it spun off in 2018 to become fully independent and 100% owned by its teams. The firm operates with a "Power of And" philosophy, managing several distinct strategies under one roof: Life Sciences (BioDiscovery), SME Growth/Buyout (MidCap, Expansion, Croissance), Sponsorless Mezzanine (Acto), and Green Infrastructure (Smart Infra). They are a heavyweight in the ecosystem, capable of supporting a biotech from clinical trials to Nasdaq IPO, or helping a family-owned SME transition to a major European group.
Key facts
- Type
- Venture Capital
- Stages
- Series A,Series B,Growth,Buyout
- Sectors
- Biotech,Medtech
- Headquarters
- France
- Offices
- Paris,Munich,Milano,Madrid,Antwerp
- Geographic focus
- France,Europe,USA
- Lead / Follow
- Lead / co-lead
- Ticket size
- 10M€ – 35M€
- Assets under management
- 4800M€
- Founded
- 2001
Track record
- Portfolio companies: 146
- Total investments: 205
- Exits: 65
Notable investments in France
Bioptimus, Amolyt Pharma, Tricares
Key differentiators
Strong Track Record,PE-backed,Sector Specialist,Pan European,Transatlantic footprint